zepbound tirzepatide injection 2.5 mg Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity It’s also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound Safety Info LP
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
























